A Phase 1 Study to Evaluate the Safety and Immunogenicity of eOD-GT8 60mer mRNA Vaccine (mRNA-1644) and Core-g28v2 60mer mRNA Vaccine (mRNA-1644v2-Core)
Clinical trial NCT05001373 · UNKNOWN
Trial details
- NCT number
- NCT05001373
- Sponsor
- International AIDS Vaccine Initiative
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-12
- Primary completion
- 2023-06-20
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.